Tobin Schilke

Companies

• Crinetics PharmaceuticalsChief financial officer Mar 5, 2025 to now¹
• Revance Therapeutics, Inc.Chief financial officer Nov 7, 2018 to Feb 6, 2025²

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

• RTRevance Therapeutics, Inc.0 shares³Feb 6, 2025
• Crinetics Pharmaceuticals0 shares⁴Sep 1, 2026

As of each latest filing. The line shows shares held over time.

Recent filings

• Sep 1, 2026Returned to company 71,471 shares at $85.00 of Crinetics Pharmaceuticals⁴
• Sep 1, 2026Returned to company 7,956 shares at $85.00 of Crinetics Pharmaceuticals⁴
• Aug 20, 2026Granted 471 shares of Crinetics Pharmaceuticals⁵
• Mar 3, 2026Sold 6,713 shares at $39.67 of Crinetics Pharmaceuticals⁶
• Feb 23, 2026Granted 32,000 shares of Crinetics Pharmaceuticals⁷
• Mar 10, 2025Granted 52,000 shares of Crinetics Pharmaceuticals⁸
• Feb 6, 2025Returned to company 20,883 shares of Revance Therapeutics, Inc.³
• Feb 6, 2025Granted 20,883 shares of Revance Therapeutics, Inc.³
• Feb 6, 2025Returned to company 103,555 shares of Revance Therapeutics, Inc.³
• Feb 4, 2025U 97,999 shares at $3.65 of Revance Therapeutics, Inc.³
• Feb 3, 2025Granted 6,888 shares of Revance Therapeutics, Inc.⁹
• Dec 31, 2024Granted 1,000 shares at $2.18 of Revance Therapeutics, Inc.¹⁰
• Jun 30, 2024Granted 1,000 shares at $2.18 of Revance Therapeutics, Inc.¹¹
• Mar 18, 2024Sold 9,361 shares at $5.04 of Revance Therapeutics, Inc.¹²
• Mar 15, 2024Shares withheld for tax 3,822 shares at $5.31 of Revance Therapeutics, Inc.¹²
• Feb 29, 2024Granted 17,447 shares of Revance Therapeutics, Inc.¹³
• Jan 31, 2024Granted 96,667 shares of Revance Therapeutics, Inc.¹⁴
• Dec 31, 2023Granted 434 shares at $7.47 of Revance Therapeutics, Inc.¹⁵
• Aug 11, 2023Shares withheld for tax 11,215 shares at $18.91 of Revance Therapeutics, Inc.¹⁶
• Aug 11, 2023Granted 22,620 shares of Revance Therapeutics, Inc.¹⁶
• Jul 3, 2023Sold 1,701 shares at $25.04 of Revance Therapeutics, Inc.¹⁷
• Jun 30, 2023Granted 769 shares at $15.61 of Revance Therapeutics, Inc.¹⁷
• Jun 2, 2023Sold 500 shares at $31.00 of Revance Therapeutics, Inc.¹⁸
• Jun 1, 2023Sold 2,701 shares at $30.57 of Revance Therapeutics, Inc.¹⁸
• May 15, 2023Sold 21,401 shares at $34.55 of Revance Therapeutics, Inc.¹⁹